Novel bi-allelic DNAH3 variants cause oligoasthenoteratozoospermia.

Shu Li, Zexin Zhang, Linna Xie, Yanqiu Zhao, Hongtai Chen, Shijia Zhang, Yixiang Cai, Bingjie Ren, Wensheng Liu, Songxi Tang, Yanwei Sha
Author Information
  1. Shu Li: Department of Andrology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  2. Zexin Zhang: Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  3. Linna Xie: Department of Andrology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  4. Yanqiu Zhao: Department of Andrology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  5. Hongtai Chen: Department of Andrology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  6. Shijia Zhang: Department of Andrology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  7. Yixiang Cai: Department of Andrology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  8. Bingjie Ren: Department of Andrology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  9. Wensheng Liu: National Health Commission (NHC) Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), Guangzhou, Guangdong, China.
  10. Songxi Tang: Department of Andrology and Sexual Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  11. Yanwei Sha: Department of Andrology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.

Abstract

Background: Oligoasthenoteratozoospermia (OAT) is a widespread cause of male infertility. One of the usual clinical manifestations of OAT is multiple morphological abnormalities of the sperm flagella (MMAF), which are frequently associated with mutations and defects in the dynein family. However, the relationship between the newly identified Dynein Axonemal Heavy Chain 3 (DNAH3) mutation and oligonasthenospermia in humans has not yet been established.
Methods: Whole exome sequencing, pathogenicity analysis, and species conservation analysis of mutation sites were conducted on two patients from different unrelated families with DNAH3 mutations. We identified representative mutation sites and predicted the protein structure following these mutations. The sperm characteristics of the two patients with DNAH3 mutations were verified using Papanicolaou staining, scanning electron microscopy, and transmission electron microscopy. Additionally, mRNA and protein levels were assessed through RT-qPCR and Western blotting.
Results: The biallelic mutations in the first progenitor included a heterozygous deletion and insertion, c.6535_6536 delinsAC (to infect mutation (p.Asp2179Thr), and stop codon premutation, c.3249G > A (p.Trp1083Ter). In Family II, the patient (P2) harbored a DNAH3 heterozygous missense mutation, c. 10439G> A(p.Arg3480Gln), along with a stop codon premutation, (c.10260G > A; p.Trp3420Ter). Patients with premature termination of transcription or translation due to DNAH3 mutations exhibit OAT phenotypes, including fibrous sheath dysplasia and multiple tail malformations. We identified the representative sites after mutation, predicted the protein structure, and assessed changes in the protein levels of DNAH3 and related genes following mutations. Notably,a significant reduction in DNAH3 protein expression was validated in these patients. We may explore in the future how DNAH3 affects sperm motility and quality through regulatory mechanisms involving protein structural changes.
Conclusion: Novel biallelic mutations in DNAH3, especially those resulting in a premature stop codon, may alter protein expression, structure, and active site, leading to spermatogenic failure and potentially inducing OAT. The discovery of new mutations in DNAH3 may be the key to the diagnosis and treatment of OAT.

Keywords

References

  1. Cell Mol Life Sci. 2020 Jun;77(11):2029-2048 [PMID: 31781811]
  2. Int J Biol Sci. 2021 Jun 16;17(10):2487-2503 [PMID: 34326689]
  3. Hum Reprod Open. 2024 Jan 11;2024(1):hoae003 [PMID: 38312775]
  4. Andrologia. 2018 Jan 22;: [PMID: 29356036]
  5. Biosci Rep. 2019 Jun 20;39(6): [PMID: 31160482]
  6. Electrophoresis. 2009 Jun;30 Suppl 1:S162-73 [PMID: 19517507]
  7. Fertil Steril. 2022 Feb;117(2):246-251 [PMID: 34986984]
  8. Nucleic Acids Res. 2022 Jul 5;50(W1):W611-W615 [PMID: 35489057]
  9. Andrology. 2015 Mar;3(2):174-202 [PMID: 25511638]
  10. Am J Hum Genet. 2008 Nov;83(5):547-58 [PMID: 18950741]
  11. Biol Reprod. 2015 Apr;92(4):95 [PMID: 25761592]
  12. Fertil Steril. 2022 Feb;117(2):252-257 [PMID: 34986981]
  13. Asian J Androl. 2012 Jan;14(1):14-23 [PMID: 22198630]
  14. J Genet Genomics. 2019 Jan 20;46(1):53-56 [PMID: 30745215]
  15. Annu Rev Biophys. 2021 May 6;50:549-574 [PMID: 33957056]
  16. Sci Rep. 2017 Sep 5;7(1):10480 [PMID: 28874689]
  17. Hum Reprod. 2018 Oct 1;33(10):1973-1984 [PMID: 30137358]
  18. Hum Reprod Update. 2021 Jun 22;27(4):697-719 [PMID: 33555313]
  19. Hum Reprod. 2023 Dec 4;38(12):2312-2320 [PMID: 37632247]
  20. Fertil Steril. 2017 Jun;107(6):1312-1318.e2 [PMID: 28577616]
  21. Eur Urol. 2021 Nov;80(5):603-620 [PMID: 34511305]
  22. Front Endocrinol (Lausanne). 2021 Nov 17;12:765639 [PMID: 34867808]
  23. Eur Urol Focus. 2023 Jan;9(1):51-54 [PMID: 36210297]
  24. J Exp Med. 2020 Feb 3;217(2): [PMID: 31658987]
  25. Biomolecules. 2022 Nov 27;12(12): [PMID: 36551192]
  26. Bioinformatics. 2020 Mar 1;36(6):1765-1771 [PMID: 31697312]
  27. Am J Hum Genet. 2020 Aug 6;107(2):330-341 [PMID: 32619401]
  28. Mol Genet Genomic Med. 2019 Aug;7(8):e807 [PMID: 31268247]
  29. Nucleic Acids Res. 2017 Jan 4;45(D1):D313-D319 [PMID: 27899672]
  30. Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303 [PMID: 29788355]
  31. Am J Hum Genet. 2021 Aug 5;108(8):1466-1477 [PMID: 34237282]
  32. Reprod Sci. 2022 Sep;29(9):2697-2702 [PMID: 35672654]
  33. Asian J Androl. 2024 Jan 1;26(1):91-98 [PMID: 37594300]
  34. Front Med. 2023 Oct;17(5):957-971 [PMID: 37314648]
  35. Exp Mol Med. 2024 Apr;56(4):827-835 [PMID: 38556551]
  36. Nucleic Acids Res. 2020 Jul 2;48(W1):W48-W53 [PMID: 32297936]
  37. Hum Genet. 2021 Jan;140(1):21-42 [PMID: 31950240]
  38. Front Endocrinol (Lausanne). 2024 Apr 30;15:1377780 [PMID: 38745955]

MeSH Term

Humans
Male
Oligospermia
Adult
Asthenozoospermia
Pedigree
Mutation
Axonemal Dyneins
Alleles
Exome Sequencing
Infertility, Male
Dyneins

Chemicals

Axonemal Dyneins
Dyneins

Word Cloud

Created with Highcharts 10.0.0DNAH3mutationsproteinmutationOATspermcpidentifiedsitespatientsstructurestopcodonmaycausemaleinfertilitymultipledyneinanalysistworepresentativepredictedfollowingelectronmicroscopylevelsassessedbiallelicheterozygouspremutation>prematurechangesexpressionNoveloligoasthenoteratozoospermiaBackground:OligoasthenoteratozoospermiawidespreadOneusualclinicalmanifestationsmorphologicalabnormalitiesflagellaMMAFfrequentlyassociateddefectsfamilyHoweverrelationshipnewlyDyneinAxonemalHeavyChain3oligonasthenospermiahumansyetestablishedMethods:WholeexomesequencingpathogenicityspeciesconservationconducteddifferentunrelatedfamiliescharacteristicsverifiedusingPapanicolaoustainingscanningtransmissionAdditionallymRNART-qPCRWesternblottingResults:firstprogenitorincludeddeletioninsertion6535_6536delinsACinfectAsp2179Thr3249GTrp1083TerFamilyIIpatientP2harboredmissense10439G>Arg3480Glnalong10260GTrp3420TerPatientsterminationtranscriptiontranslationdueexhibitphenotypesincludingfibroussheathdysplasiatailmalformationsrelatedgenesNotablysignificantreductionvalidatedexplorefutureaffectsmotilityqualityregulatorymechanismsinvolvingstructuralConclusion:especiallyresultingalteractivesiteleadingspermatogenicfailurepotentiallyinducingdiscoverynewkeydiagnosistreatmentbi-allelicvariantsintracytoplasmicinjection

Similar Articles

Cited By